GoodRx Holdings GDRX Ratios (2019-2026)

NASDAQ GDRX
$3.37 +0.01 (+0.30%)
At close: Oct 19, 2026 · 4:00 PM EDT
Reported Financials

GoodRx Holdings Quarterly Ratios

Periods 28 quarters
Latest Jun 2026

GoodRx Holdings reported a gross margin of 89.52% and a net margin of 4.26% for the quarter ended Jun 2026. These financial ratios cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

RatiosRatios Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
94.22%93.47%93.96%90.59%90.71%90.57%90.93%91.39%89.60%92.29%93.70%94.08%94.02%93.86%93.42%93.43%93.15%91.03%89.61%89.52%
EBT Margin
0.56%2.75%6.86%-5.30%-11.89%-2.58%1.95%6.36%-25.90%-12.53%0.15%5.81%4.15%5.75%8.21%9.64%3.11%7.29%2.91%7.72%
EBIT Margin
3.59%5.51%9.72%-2.11%-8.39%0.94%6.14%9.65%-21.30%-9.30%3.73%9.91%10.45%9.15%11.52%13.20%7.46%11.65%7.22%11.79%
EBITDA Margin
9.24%10.91%15.73%5.28%-0.49%9.84%14.72%18.58%-2.48%13.30%12.21%18.78%19.64%18.98%22.03%23.13%18.62%23.76%18.69%23.14%
Operating Margin
3.59%5.51%9.72%-2.11%-8.39%0.94%6.14%9.65%-21.30%-9.30%3.73%9.91%10.45%9.15%11.52%13.20%7.46%11.65%7.22%11.79%
Net Margin
-9.26%-18.72%6.05%-0.74%-22.28%-1.07%-1.79%30.99%-21.39%-13.16%-0.51%3.34%2.03%3.39%5.45%6.32%0.57%2.79%0.60%4.26%
FCF Margin
24.53%22.98%13.96%25.87%17.66%17.23%17.47%15.59%33.38%7.86%21.32%4.70%44.28%22.45%4.57%24.22%37.89%16.25%5.52%40.15%
Efficiency
Assets AverageAssets Avg.
1,600.65M1,611.00M1,572.98M1,565.16M1,579.53M1,585.85M1,608.07M1,651.80M1,700.04M1,648.39M1,521.38M1,464.68M1,415.12M1,371.46M1,341.67M1,306.99M1,322.11M1,364.78M1,712.65M2,182.09M
Equity AverageEquity Avg.
835.40M839.04M809.09M802.22M803.17M801.62M821.15M861.42M888.32M821.62M696.51M650.23M682.92M710.55M689.50M648.69M621.87M608.49M619.12M634.79M
Invested CapitalInvested Cap.
1,510.29M1,494.57M1,448.38M1,478.80M1,448.25M1,473.65M1,485.27M1,552.15M1,537.03M1,418.45M1,284.78M1,322.08M1,187.78M1,216.37M1,145.18M1,133.00M1,089.83M1,104.53M1,109.41M1,134.19M
Asset Utilization RatioAsset Util.
0.430.460.500.510.500.480.460.450.430.460.500.530.560.580.590.610.610.580.460.36
Leverage & Solvency
Interest Coverage RatioInterest Cover
1.181.993.37-0.58-1.660.150.861.30-2.60-1.230.501.361.651.602.202.501.352.181.432.41
Debt Ratio
0.410.410.430.420.420.410.410.390.380.410.450.440.360.350.380.370.370.350.240.21
Times Interest Earned
1.181.993.37-0.58-1.660.150.861.30-2.60-1.230.501.361.651.602.202.501.352.181.432.41
Valuation
Price to EarningsP/E
185.72149.23108.6155.9350.7745.4530.3632.1960.28
Price to SalesP/S
23.8517.569.712.932.322.413.322.943.043.523.483.813.342.252.002.201.801.160.841.25
Price to BookP/B
19.3215.749.742.882.352.273.002.452.543.474.224.413.792.462.432.732.401.501.061.51
Enterprise Value
15,441.87M12,149.26M6,811.80M1,625.08M1,120.84M1,092.97M1,717.98M1,427.64M1,447.87M1,968.09M2,128.80M2,428.23M2,218.95M1,331.74M1,290.20M1,475.48M1,169.63M662.43M425.94M683.46M
EV to EBIT
906.26178.4847.1595.33628.8791.3175.5320.2315.7616.6214.097.575.459.12
EV to EBITDA
236.4182.9219.4917.3918.4231.5617.9519.0523.4226.2529.0717.569.668.148.807.053.802.574.13
Market Capitalization
16,353.89M13,090.37M7,657.23M2,355.62M1,849.62M1,850.14M2,479.06M2,189.63M2,242.78M2,640.38M2,662.10M2,953.13M2,642.72M1,780.09M1,591.19M1,756.80M1,443.16M924.25M661.65M979.57M
Price to FCFP/FCF
120.9875.1447.9113.4711.5512.9516.9117.3114.6119.2418.0723.2317.219.7510.639.278.145.623.994.97
EV to FCF
114.2369.7442.629.297.007.6511.7211.289.4314.3414.4519.1014.457.298.627.796.604.032.573.47
EV to CFO
107.3767.9641.689.056.807.4511.5311.179.3814.2314.3318.9114.317.248.567.746.513.952.503.39
Return Ratios
Return on Sales [ROS]ROS
3.59%5.51%9.72%-2.11%-8.39%0.94%6.14%9.65%-21.30%-9.30%3.73%9.91%10.45%9.15%11.52%13.20%7.46%11.65%7.22%11.79%
Return on Capital Employed [ROCE]ROCE
-19.49%0.88%2.52%2.32%0.79%0.12%-0.44%1.00%-0.44%-1.77%-2.20%-2.16%2.26%5.28%6.61%7.55%7.28%7.82%9.15%7.32%
Return on Invested Capital [ROIC]ROIC
-17.51%0.89%0.00%0.00%0.80%0.12%-0.45%0.00%0.00%-0.29%-0.26%-2.23%2.34%2.85%4.12%4.84%4.41%4.29%3.19%2.62%
Return on Assets [ROA]ROA
-17.72%-1.57%-0.93%-3.01%-4.48%-2.07%-3.01%0.71%0.88%-0.54%-0.43%-4.01%-1.15%1.20%2.12%2.65%2.40%2.23%1.20%0.74%
Return on Equity [ROE]ROE
-33.95%-3.01%-1.81%-5.87%-8.81%-4.10%-5.90%1.37%1.69%-1.08%-0.95%-9.02%-2.37%2.31%4.13%5.33%5.11%5.00%3.32%2.56%

GoodRx Holdings Ratios API

Pull GoodRx Holdings's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/statements?ticker=GDRX&statement=Ratios&frequency=Quarter&period=all&api_key=YOUR_API_KEY